Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Low conversion rate of QuantiFERON-TB Gold screening tests in patients treated with tumor necrosis factor inhibitors: A retrospective cohort study identifying an important practice gap. J Am Acad Dermatol 2018 Jul;79(1):169-171

Date

03/29/2018

Pubmed ID

29588247

DOI

10.1016/j.jaad.2018.03.025

Scopus ID

2-s2.0-85048403332 (requires institutional sign-in at Scopus site)   14 Citations

Author List

Chung J, Aronson AB, Srikantha R, Vogelgesang SA, Wanat KA

Author

Karolyn A. Wanat MD Chair, Professor in the Dermatology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Arthritis, Rheumatoid
Cohort Studies
Female
Follow-Up Studies
Humans
Inflammatory Bowel Diseases
Interferon-gamma Release Tests
Male
Mass Screening
Middle Aged
Professional Practice Gaps
Psoriasis
Retrospective Studies
Risk Assessment
Treatment Outcome
Tuberculosis
Tumor Necrosis Factor-alpha
United States